Glomerulonephritis Disease

BASICS

DESCRIPTION
An immunologic response to an infection (usually streptococcal) which damages the renal glomeruli. It can be initiated by other bacterial and viral infections. This is an immune complex, hypocomplementemic glomerulonephritis. Most common in children. Characterized by diffuse inflammatory changes in the glomeruli and clinically by the abrupt onset of hematuria with red blood cell casts, and mild proteinuria. Accompanied in many cases by hypertension, edema, and azotemia.
  • System(s) affected: Renal/Urologic
  • Genetics: No known genetic pattern
  • Incidence/Prevalence in USA: 20/100,000/year (1-2% of pyodermas and 8% of streptococcal infections in children; occurs with impetigo in the late summer and with streptococcal pharyngitis in the winter)
  • Predominant age:
    • 60% of cases in children 2-12 years old
    • Only 10% older than 40 years of age
  • Predominant sex: Male > Female (60:40)
SIGNS AND SYMPTOMS
  • Classic findings of acute nephritis
    • Hematuria (100%)
    • Oliguria or anuria (52%)
    • Edema (85%)
    • Hypertension (82%)
    • Hypocomplementemia (C3) (83%)
    • Gross hematuria (30%), tea-colored urine
    • Edema of face and eyes in the am and feet and ankles in the afternoons and evenings
    • Fever (rare)
  • Other signs and symptoms
    • Pharyngitis
    • Respiratory infection
    • Scarlet fever
    • Dark urine
    • Weight gain
    • Abdominal pain
    • Anorexia
    • Back pain
    • Pallor
    • Impetigo
CAUSES
  • Follows group A beta-hemolytic streptococcus infection
  • "Nephritogenic" strains of strep - groups 1, 4, 11, 12, 49 "Red Lake", 55, 60
  • Unusual to have a second attack - protective immunity to nephritogenic antigen
  • Cases of "postinfective" glomerulonephritis have also been reported from pneumococcus, staphylococcus, meningococcus, chickenpox, and hepatitis
  • Streptococcal infection precedes renal lesions by 1-3 weeks
  • Pharyngitis precedes renal lesions by 1-2 weeks (types 1, 2, 4, 12)
  • Impetigo (types 49, 55, 57) usually precedes throat or otitis media infection by 2-4 weeks
RISK FACTORS
  • 15% occurrence rate after infection with nephritogenic strain
  • Endemic with cyclic epidemics
  • Subclinical cases 20 times more common
  • Streptococcal infection (e.g., scarlet fever or erysipelas) can be associated with rheumatic fever or acute glomerulonephritis, rarely both

DIAGNOSIS

LABORATORY
  • Streptococcal tests (Streptozyme) that include many antigens are most sensitive (+ or -) for screening but not quantitative
  • Antistreptolysin O (ASO) - quantitative titer. Increased in 60-80% of cases. Increase begins 1-3 weeks, is highest 3-5 weeks, normal in 6 months. ASO titer is unrelated to severity, duration or prognosis of renal disease.
  • Red blood cells casts on urinalysis:
    • destroyed by centrifugation
    • disintegrate in urine, particularly alkaline urine
  • Characteristically, red blood cells from glomerular bleeding are distorted while those from lower urinary tract have normal morphology
  • U/P creatinine > 40, decreased renin
  • Culture throat and skin lesions for streptococcus
  • C3 and C4 complements are best for evaluation
  • Streptozyme
  • Hypertriglyceridemia
  • Proteinuria
  • Decreased glomerular filtration rate
  • Uremia
  • Increased serum creatinine
  • Anemia
  • ANA to rule out systemic lupus erythematosus

Drugs that may alter lab results: N/A
Disorders that may alter lab results: N/A

PATHOLOGICAL FINDINGS
  • On renal biopsy
    • Diffuse proliferative and exudative glomerulonephritis
    • Electron microscopy - subepithelial deposits
    • Immunofluorescence - C3 in almost all cases, some with IgG and IgM
SPECIAL TESTS
N/A
IMAGING
X-rays and/or ultrasound are not necessary to make the diagnosis
DIAGNOSTIC PROCEDURES
  • If progressive, consider renal biopsy. Biopsy usually not indicated.

TREATMENT

APPROPRIATE HEALTH CARE
  • Most patients can be safely followed as outpatients
  • Inpatient usually until blood pressure and creatinine normalized and edema begins to recede
GENERAL MEASURES
  • Decrease salt: no-added salt diet until edema and hypertension clear
  • Decrease fluids to insensible losses plus 2/3 of the urine output until diuresis
  • Control hypertension with diuretics
  • Dialysis: peritoneal dialysis or hemodialysis for symptomatic azotemia, unresponsive hyperkalemia, intractable acidosis, diuretic resistant pulmonary edema
SURGICAL MEASURES

N/A

ACTIVITY

Can return to full activity after clinically improved. May have increased hematuria after exercise for up to two years.

DIET
  • "No-added" salt diet until edema, hypertension, and azotemia clear
  • Restrict protein in presence of azotemia and metabolic acidosis
  • Avoid high potassium foods
PATIENT EDUCATION
  • National Kidney Foundation, 30 E. 33rd Street, Suite 1100, New York, NY 10016, (212)889-2210
  • Web site - www.healthanswers.com

FOLLOW UP

PREVENTION/AVOIDANCE

Treat streptococcal infections aggressively

POSSIBLE COMPLICATIONS
  • Hypertensive retinopathy
  • Hypertensive encephalopathy
  • Rapidly progressive glomerulonephritis
  • Abnormal urinalysis may persist for years (microhematuria)
  • Chronic renal failure (rare)
  • Nephrotic syndrome (approximately 10%)
  • Marked decline in glomerular filtration rate (rare)
EXPECTED COURSE AND PROGNOSIS
  • Usually self-limited to 2-3 weeks
  • Immediate mortality < 0.5%
  • Long-term: excellent in children; almost all patients recover completely
  • May have more morbidity in adults or in those with pre-existing renal lesions
  • Microscopic hematuria may persist for 24 months (or longer with complete recovery)
  • Proteinuria persists for up to 3 months
  • Symptoms can be exacerbated by an intercurrent illness but rarely after 12 months
  • Urine may be darker (microscopic hematuria) after strenuous exercise

MISCELLANEOUS

ASSOCIATED CONDITIONS

N/A

AGE-RELATED FACTORS

Pediatric: Common in children ages 2-16
Geriatric: N/A
Others: N/A

PREGNANCY

N/A

OTHER NOTES

N/A

ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.